Skip to main content
Log in

Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea

  • Case Report
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Chorea is a rare complication of systemic lupus erythematosus (SLE) and is strongly related to the presence of antiphospholipid antibodies. Various infections may also be triggering factors in the development of choreiform movements. Additionally, Salmonella infection is the most common opportunistic bacterial infection in SLE patients. We report a case of a 33-year-old woman with SLE who developed lupus erythematosus-associated chorea with multiple involuntary movements and cognitive disturbances. Because the methylprednisolone therapy administered appeared to lead to Salmonella enteritidis infection, intravenous immunoglobulin (IVIg) in a total dose 100 g was administered after which a remarkable improvement of the abnormal movements and cognitive function was noted. Within 7 days, the patient had returned to normal. We therefore conclude that IVIg therapy may be an effective therapeutic approach for the treatment of the acute cerebral complications of SLE, especially in cases in whom other therapeutic strategies are ineffective or harmful.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Asherson RA, Cervera R (2003) The antiphospholipid syndrome: multiple faces beyond the classical presentation. Autoimmunity Reviews 2(3):140–151

    Article  PubMed  Google Scholar 

  2. Asherson RA, Cervera R, Shepshelowich D, Shoenfeld Y (2006) Nonthrombotic manifestations of the antiphospholipid syndrome: away from thrombosis ? J Rheumatol 33(6):1038–1044

    PubMed  Google Scholar 

  3. Blaauw AA, Tobe TJ, Derksen RW, Bijlsma JW (2000) A patient with systemic lupus erythematosus and Salmonella enteritidis bacteraemia complicated by rhabdomyolysis and acute cholecystitis. Rheumatology (Oxford) 39(1):110–112

    Article  CAS  Google Scholar 

  4. Brey RL, Holliday SL, Saklad AR, Navarrete MG, Hermosillo-Romo D, Stallworth CL, Valdez CR, Escalante A, del Rincon I, Gronseth G, Rhine CB, Padilla P, McGlasson D (2002) Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 58(8):1214–1220

    Article  CAS  PubMed  Google Scholar 

  5. Cervera R, Asherson RA, Font J, Tikly M, Pallares L, Chamorro A, Ingelmo M (1997) Chorea in the antiphospholipid syndrome: clinical, radiologic and immunologic characteristics of 50 patients from our clinics and the recent literature. Medicine (Baltimore) 76(3):203–212

    Article  CAS  Google Scholar 

  6. Hsu RB, Chen RJ, Chu SH (2004) Risk factors for recurrent bacteremia in adult patients with nontyphoid salmonellosis. Am J Med Sci 238(6):315–318

    Article  Google Scholar 

  7. Janavs JL, Aminoff MJ (1998) Dystonia and chorea in aquired systemic disorders. J Neurol Neurosurg Psychiatry 65(4):436–445

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Oh HM, Chng HH, Boey ML, Feng PH (1993) Infections in systemic lupus erythematosus. Singapore Med J 34(5):406–408

    CAS  PubMed  Google Scholar 

  9. Rafai MA, El Moutawakil B, Gam I, Hakim K, Fadel H, Kissani N, Slassi I (2005) Systemic lupus erythematosus presenting with a choreoathetotic syndrome associated with antiphospholipid antibodies. Rev Neurol (Paris) 161(10):967–970

    Article  CAS  Google Scholar 

  10. Rutberg SA, Ward DE, Roth BJ (2002) Churg–Strauss syndrome and pregnancy: successful treatment with intravenous immunoglobulin. J Clin Rheumatol 8(3):151–156

    Article  PubMed  Google Scholar 

  11. Sherer Y, Levy Y, Langewitz P, Lorber M, Fabrizzi F, Shoenfeld Y (1999) Successful treatment of systemic lupus erythematosus cerebritis with intravenous immunoglobulin. Clin Rheumatol 18:170–173

    Article  CAS  PubMed  Google Scholar 

  12. Steinbrecher A, Berlit P (2006) Intravenous immunoglobulin treatment in vasculitis and connective tissue disorders. J Neurol 5(Suppl 253):v39–v49

    Article  Google Scholar 

  13. Tomer Y, Shoenfeld Y (1992) Successful treatment of psychosis secondary to SLE with high dose intravenous immunoglobulin. Clin Exp Rheumatol 10(4):391–393

    CAS  PubMed  Google Scholar 

  14. Wang TK, Ho PL, Wong SS (2005) Recurrent bacteraemia caused by different Salmonella species in a systemic lupus erythematosus patient. New Microbiol 28(2):151–156

    PubMed  Google Scholar 

  15. Watanabe T, Onda H (2004) Hemichorea with antiphospholipid antibodies in a patient with lupus nephritis. Pediatr Nephrol 19(4):451–453

    Article  PubMed  Google Scholar 

  16. Wongchinsri J, Tantawichien T, Osiri M, Akkasilpa S, Deesomchok U (2002) Infection in Thai patients with systemic lupus erythematosus: a review of hospitalized patients. J Med Assoc Thail 85 (Suppl 1):34–39

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to I. Lazurova.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lazurova, I., Macejova, Z., Benhatchi, K. et al. Efficacy of intravenous immunoglobulin treatment in lupus erythematosus chorea. Clin Rheumatol 26, 2145–2147 (2007). https://doi.org/10.1007/s10067-007-0627-9

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-007-0627-9

Keywords

Navigation